Delivery Order SPE2DX22D0010-SPE2D826FAB76
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,707.27 to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,480.85 to AmerisourceBergen Drug Corp for Metadate CD Caps 10mg on June 26, 2025, with an ultimate completion date of June 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $8,397.85 with a completion deadline of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metadate CD Caps 10mg, a methylphenidate-based medication used in the treatment of attention deficit hyperactivity disorder. The contract, valued at $3,183.82 with a firm fixed price structure, was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,086.87 for Metadate CD Caps 50mg under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a competitively awarded procurement with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,749.22 to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This non-competitive, firm fixed-price delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $16,551.16, represents a non-competitive set-aside award and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Metadate CD 20 mg capsules (30-count supply) with a ceiling value of $1,588.92. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is executed under AmerisourceBergen...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg with a ceiling value of $7,919.77 under a firm fixed-price contract. This non-competitive delivery order, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, represents a small-value transaction for pharmaceutical supply. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's corporate headquarters...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Metadate CD Caps 20mg, a medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $7,322.65 with an ultimate completion date of April 25, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's Corporate Office...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAB76Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,396.82 to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg on October 3, 2025, with completion targeted for October 6, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitively awarded delivery order pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Metadate CD (methylphenidate extended-release capsules) is a controlled pharmaceutical used in the treatment of attention deficit hyperactivity disorder. This delivery order fulfills a portion of the broader pharmaceutical supply requirements under the DLA's global pharmaceutical support program, which enables AmerisourceBergen to supply medications and medical commodities to military healthcare systems, the Defense Health Agency, and other federal health entities worldwide. The contract demonstrates the company's capability to deliver specialized pharmaceutical products through the federal procurement process on a firm fixed-price basis, supporting ongoing military medical readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 10/3/25 |